LETROZOLE TABLETS

LETROZOLE TABLETS was reported 48906 times

LETROZOLE TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PIK3CA-ACTIVATED MUTATION 167 0.5030
1 HORMONE RECEPTOR POSITIVE HER2 NEGATIVE BREAST CANCER 136 0.4096
2 CARBOHYDRATE ANTIGEN 15-3 INCREASED 257 0.3377
3 AMAUROSIS FUGAX 232 0.2154
4 HORMONE RECEPTOR POSITIVE BREAST CANCER 58 0.2132
5 PLEURAL NEOPLASM 30 0.1818
6 METASTASES TO CHEST WALL 58 0.1671
7 METASTASES TO ABDOMINAL WALL 32 0.1608
8 BREAST CANCER METASTATIC 1712 0.1593
9 PSEUDOCIRRHOSIS 46 0.1386
10 TUMOUR MARKER ABNORMAL 45 0.1360
11 METASTASES TO SKIN 137 0.1326
12 METASTASES TO PLEURA 136 0.1296
13 INVASIVE LOBULAR BREAST CARCINOMA 65 0.1267
14 METASTASES TO THE MEDIASTINUM 52 0.1262
15 METASTASES TO EYE 26 0.1187
16 METASTASES TO BONE 1901 0.1157
17 METASTASES TO THORAX 26 0.1028
18 INVASIVE BREAST CARCINOMA 42 0.1017
19 BONE MARROW INFILTRATION 38 0.0982
20 METASTASES TO PELVIS 60 0.0949
21 NEUTROPHIL PERCENTAGE DECREASED 47 0.0882
22 TUMOUR MARKER INCREASED 420 0.0874
23 BREAST CANCER RECURRENT 276 0.0873
24 METASTASES TO STOMACH 32 0.0816
25 INTESTINAL METASTASIS 29 0.0799
26 LYMPHOCYTE PERCENTAGE INCREASED 32 0.0790
27 METASTASES TO LIVER 1357 0.0771
28 INVASIVE DUCTAL BREAST CARCINOMA 206 0.0757
29 BREAST CONSERVING SURGERY 38 0.0742
30 METASTASES TO SPINE 243 0.0722
31 NEOPLASM PROGRESSION 2439 0.0701
32 METASTASES TO BONE MARROW 34 0.0680
33 METASTASES TO LYMPH NODES 453 0.0671
34 CARCINOEMBRYONIC ANTIGEN INCREASED 130 0.0670
35 BONE LESION 235 0.0651
36 METASTASES TO PERITONEUM 156 0.0617
37 MEAN CELL HAEMOGLOBIN INCREASED 101 0.0610
38 OSTEOSCLEROSIS 93 0.0590
39 METASTASES TO LUNG 682 0.0590
40 OVARIAN CANCER RECURRENT 92 0.0572
41 ANISOCYTOSIS 37 0.0563
42 OVARIAN HYPERSTIMULATION SYNDROME 131 0.0562
43 BASOPHIL COUNT INCREASED 42 0.0554
44 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 68 0.0546
45 LYMPHANGIOSIS CARCINOMATOSA 53 0.0509
46 METASTASES TO ADRENALS 46 0.0498
47 PLEURAL DISORDER 31 0.0494
48 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 27 0.0485
49 MONOCYTE COUNT DECREASED 59 0.0483
50 MONOCYTE PERCENTAGE INCREASED 34 0.0480
51 MEAN CELL VOLUME INCREASED 123 0.0479
52 PERITONEAL DISORDER 31 0.0478
53 NAIL DYSTROPHY 26 0.0464
54 URINARY TRACT DISORDER 207 0.0459
55 HYDROTHORAX 38 0.0458
56 LYMPHOEDEMA 309 0.0446
57 PLEURAL THICKENING 29 0.0424
58 DEVICE RELATED THROMBOSIS 41 0.0416
59 OVARIAN CANCER METASTATIC 35 0.0412
60 DECREASED IMMUNE RESPONSIVENESS 401 0.0408
61 POSITRON EMISSION TOMOGRAM ABNORMAL 27 0.0386
62 MALIGNANT PLEURAL EFFUSION 65 0.0385
63 METASTASIS 271 0.0379
64 OSTEOLYSIS 77 0.0376
65 CANCER PAIN 96 0.0375
66 HILAR LYMPHADENOPATHY 33 0.0375
67 SECOND PRIMARY MALIGNANCY 311 0.0374
68 MACROCYTOSIS 43 0.0371
69 MALIGNANT NEOPLASM PROGRESSION 3695 0.0360
70 SKIN HYPOPIGMENTATION 62 0.0350
71 NEUTROPENIA 4676 0.0344
72 TRIGGER FINGER 139 0.0340
73 RADIATION SKIN INJURY 39 0.0336
74 METASTASES TO MENINGES 76 0.0334
75 HEPATIC LESION 144 0.0333
76 MUCOSAL DRYNESS 67 0.0332
77 HAEMORRHAGIC STROKE 251 0.0321
78 LYMPHADENOPATHY MEDIASTINAL 60 0.0313
79 NEUTROPHIL COUNT ABNORMAL 86 0.0304
80 WHITE BLOOD CELL COUNT DECREASED 3281 0.0302
81 MENOPAUSAL SYMPTOMS 70 0.0300
82 BREAST NEOPLASM 31 0.0300
83 RED CELL DISTRIBUTION WIDTH INCREASED 124 0.0298
84 VITILIGO 70 0.0298
85 DILATED CARDIOMYOPATHY 30 0.0297
86 BLOOD BILIRUBIN ABNORMAL 38 0.0297
87 ASPARTATE AMINOTRANSFERASE ABNORMAL 45 0.0295
88 SUBCLAVIAN VEIN THROMBOSIS 33 0.0290
89 OVARIAN CANCER 264 0.0286
90 FULL BLOOD COUNT ABNORMAL 300 0.0283
91 ONYCHOCLASIS 195 0.0283
92 FEBRILE INFECTION 33 0.0280
93 OVARIAN DISORDER 26 0.0277
94 BILE DUCT STENOSIS 33 0.0275
95 HAEMATOTOXICITY 260 0.0273
96 MASTECTOMY 47 0.0269
97 NEUTROPHIL COUNT DECREASED 1088 0.0267
98 LEUKOPENIA 1316 0.0263
99 NAIL DISORDER 230 0.0263
100 VULVOVAGINAL DRYNESS 85 0.0263
101 HEPATOTOXICITY 573 0.0257
102 ALANINE AMINOTRANSFERASE ABNORMAL 52 0.0246
103 BREAST DISORDER 50 0.0245
104 AXILLARY PAIN 36 0.0242
105 PATHOLOGICAL FRACTURE 121 0.0238
106 METASTASES TO CENTRAL NERVOUS SYSTEM 305 0.0236
107 POLYNEUROPATHY 280 0.0234
108 WHITE BLOOD CELL COUNT ABNORMAL 147 0.0230
109 ERYSIPELAS 115 0.0229
110 RED BLOOD CELL COUNT DECREASED 653 0.0228
111 FULL BLOOD COUNT DECREASED 459 0.0228
112 MADAROSIS 264 0.0227
113 HAIR DISORDER 186 0.0226
114 OCULAR DISCOMFORT 251 0.0223
115 BODY MASS INDEX INCREASED 30 0.0222
116 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 37 0.0222
117 ASCITES 646 0.0220
118 OSTEONECROSIS OF JAW 539 0.0218
119 GENE MUTATION 43 0.0217
120 BREAST MASS 142 0.0211
121 HEPATIC MASS 40 0.0207
122 HEPATIC CYTOLYSIS 259 0.0203
123 CALCIUM DEFICIENCY 26 0.0201
124 AORTIC ARTERIOSCLEROSIS 51 0.0198
125 CONCOMITANT DISEASE AGGRAVATED 122 0.0197
126 HAIR TEXTURE ABNORMAL 264 0.0197
127 LUNG OPACITY 52 0.0197
128 SPINAL PAIN 230 0.0196
129 ONYCHOMADESIS 82 0.0195
130 GRANULOCYTE COUNT DECREASED 36 0.0194
131 GENERALISED OEDEMA 232 0.0187
132 SKIN TOXICITY 104 0.0184
133 RED BLOOD CELL COUNT ABNORMAL 27 0.0184
134 BILIARY DILATATION 27 0.0184
135 BREAST CANCER STAGE IV 52 0.0183
136 BONE PAIN 1056 0.0180
137 HEAD DISCOMFORT 313 0.0177
138 CUTANEOUS LUPUS ERYTHEMATOSUS 34 0.0175
139 ORGANISING PNEUMONIA 86 0.0173
140 HYDRONEPHROSIS 127 0.0169
141 GAMMA-GLUTAMYLTRANSFERASE INCREASED 375 0.0169
142 THORACIC VERTEBRAL FRACTURE 50 0.0169
143 NEOPLASM RECURRENCE 57 0.0168
144 ELECTROCARDIOGRAM QT PROLONGED 594 0.0165
145 HOT FLUSH 1241 0.0164
146 CARBOHYDRATE ANTIGEN 125 INCREASED 56 0.0164
147 HAIR COLOUR CHANGES 203 0.0163
148 BLOOD COUNT ABNORMAL 246 0.0162
149 HUMERUS FRACTURE 75 0.0155
150 WHITE BLOOD CELL DISORDER 41 0.0153
151 PSYCHOLOGICAL TRAUMA 132 0.0153
152 PULMONARY MASS 227 0.0152
153 TRANSAMINASES INCREASED 328 0.0147
154 BREAST PAIN 157 0.0147
155 BONE CANCER 64 0.0147
156 GLOMERULAR FILTRATION RATE DECREASED 180 0.0146
157 ALOPECIA 2863 0.0146
158 CHEST INJURY 30 0.0145
159 BREAST CANCER 1350 0.0145
160 DISEASE PROGRESSION 1708 0.0144
161 HEPATIC CYST 49 0.0144
162 METASTATIC NEOPLASM 62 0.0144
163 CYSTOID MACULAR OEDEMA 27 0.0143
164 OSTEOPOROTIC FRACTURE 27 0.0141
165 PLEURAL EFFUSION 856 0.0141
166 PROTEIN TOTAL INCREASED 37 0.0139
167 STOMATITIS 836 0.0138
168 DYSCHEZIA 42 0.0137
169 BLOOD ALKALINE PHOSPHATASE INCREASED 340 0.0137
170 LYMPHADENITIS 33 0.0136
171 BLOOD CREATININE ABNORMAL 47 0.0136
172 MUCOSAL INFLAMMATION 352 0.0134
173 TASTE DISORDER 268 0.0132
174 PERIARTHRITIS 30 0.0132
175 LIVER FUNCTION TEST INCREASED 281 0.0131
176 ASPARTATE AMINOTRANSFERASE INCREASED 695 0.0131
177 THERAPY PARTIAL RESPONDER 202 0.0129
178 ADENOCARCINOMA 29 0.0129
179 PERIODONTITIS 28 0.0129
180 VITREOUS DETACHMENT 28 0.0129
181 BONE MARROW DISORDER 39 0.0129
182 LYMPHOCYTE COUNT INCREASED 42 0.0129
183 HAEMATOCRIT DECREASED 255 0.0128
184 HYPERTRANSAMINASAEMIA 89 0.0128
185 PNEUMONITIS 347 0.0127
186 ANAEMIA MACROCYTIC 27 0.0126
187 ORTHOPNOEA 40 0.0125
188 APHTHOUS ULCER 96 0.0124
189 RECURRENT CANCER 50 0.0122
190 EOSINOPHIL COUNT DECREASED 29 0.0122
191 TACHYARRHYTHMIA 30 0.0120
192 ALTERED STATE OF CONSCIOUSNESS 257 0.0119
193 ALANINE AMINOTRANSFERASE INCREASED 728 0.0118
194 HAEMATEMESIS 298 0.0117
195 MUSCULOSKELETAL CHEST PAIN 180 0.0116
196 PHOTOPHOBIA 218 0.0116
197 FEMORAL NECK FRACTURE 59 0.0115
198 DYSAESTHESIA 35 0.0114
199 PLATELET COUNT ABNORMAL 69 0.0114
200 EJECTION FRACTION DECREASED 177 0.0114
201 MONOCYTE COUNT INCREASED 41 0.0113
202 OBSTRUCTION 45 0.0113
203 CYTOPENIA 137 0.0112
204 BILIRUBIN CONJUGATED INCREASED 26 0.0111
205 DIPLOPIA 288 0.0111
206 BONE DISORDER 202 0.0111
207 HAEMOGLOBIN ABNORMAL 71 0.0110
208 PORTAL HYPERTENSION 34 0.0110
209 PRESYNCOPE 267 0.0110
210 BLOOD BILIRUBIN INCREASED 294 0.0109
211 HEPATIC STEATOSIS 200 0.0107
212 NEUTROPENIC SEPSIS 76 0.0106
213 BLOOD CREATININE DECREASED 33 0.0105
214 ORAL PAIN 235 0.0105
215 LYMPHADENOPATHY 371 0.0105
216 BLOOD TEST ABNORMAL 145 0.0103
217 SPINAL CORD COMPRESSION 40 0.0103
218 ISCHAEMIC STROKE 182 0.0102
219 CACHEXIA 52 0.0101
220 NEOPLASM 116 0.0101
221 HEPATIC NECROSIS 38 0.0101
222 BLOOD CALCIUM DECREASED 113 0.0100
223 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 233 0.0100
224 BILIARY COLIC 29 0.0100
225 THROMBOCYTOPENIA 1109 0.0099
226 HYPERSENSITIVITY VASCULITIS 26 0.0099
227 HYPERCALCAEMIA 122 0.0099
228 HYPERURICAEMIA 40 0.0097
229 BLOOD CREATININE INCREASED 628 0.0096
230 ANAEMIA 1823 0.0095
231 NEUROPATHY PERIPHERAL 899 0.0094
232 NASAL DRYNESS 59 0.0094
233 MYELOSUPPRESSION 336 0.0093
234 DRUG TOLERANCE DECREASED 26 0.0092
235 BLOOD CALCIUM INCREASED 81 0.0092
236 HAEMOGLOBIN DECREASED 941 0.0092
237 PARONYCHIA 40 0.0091
238 SYNOVIAL CYST 42 0.0091
239 PLATELET COUNT DECREASED 968 0.0091
240 LYMPHOPENIA 128 0.0090
241 LACRIMATION INCREASED 273 0.0090
242 LEFT VENTRICULAR FAILURE 31 0.0090
243 MONOPLEGIA 39 0.0090
244 OSTEOPENIA 136 0.0090
245 HEPATOMEGALY 88 0.0089
246 GASTROINTESTINAL TOXICITY 43 0.0089
247 LUMBAR VERTEBRAL FRACTURE 41 0.0089
248 DIVERTICULUM INTESTINAL 39 0.0089
249 NAIL DISCOLOURATION 35 0.0089
250 MATERNAL EXPOSURE BEFORE PREGNANCY 59 0.0086
251 CARDIOTOXICITY 77 0.0086
252 DECREASED APPETITE 1993 0.0086
253 EATING DISORDER 182 0.0085
254 OCULAR ICTERUS 37 0.0085
255 HYPOCALCAEMIA 161 0.0085
256 PROTEIN TOTAL DECREASED 32 0.0085
257 MOUTH SWELLING 49 0.0085
258 LYMPHOCYTE COUNT DECREASED 150 0.0085
259 ORAL DISORDER 62 0.0084
260 HEPATIC FIBROSIS 29 0.0084
261 HEPATIC NEOPLASM 27 0.0083
262 TONGUE DISCOMFORT 35 0.0082
263 LEFT VENTRICULAR DYSFUNCTION 55 0.0082
264 BLOOD PHOSPHORUS DECREASED 30 0.0082
265 HYPERTENSIVE CRISIS 91 0.0082
266 VENOUS THROMBOSIS 32 0.0081
267 DYSPNOEA EXERTIONAL 307 0.0081
268 BLOOD URIC ACID INCREASED 47 0.0081
269 CARPAL TUNNEL SYNDROME 113 0.0081
270 CEREBRAL HAEMATOMA 27 0.0080
271 BLOOD LACTATE DEHYDROGENASE INCREASED 127 0.0080
272 JOINT STIFFNESS 210 0.0080
273 GROIN PAIN 70 0.0080
274 CUTANEOUS VASCULITIS 29 0.0079
275 FATIGUE 6184 0.0079
276 JAUNDICE CHOLESTATIC 28 0.0079
277 MUSCULOSKELETAL DISCOMFORT 136 0.0079
278 BLINDNESS 321 0.0079
279 FIBRIN D DIMER INCREASED 28 0.0079
280 INTERSTITIAL LUNG DISEASE 379 0.0078
281 TOOTHACHE 141 0.0078
282 CHOLESTASIS 149 0.0078
283 IMMUNOSUPPRESSION 68 0.0077
284 FEEDING DISORDER 156 0.0077
285 THROMBOCYTOSIS 28 0.0076
286 DRUG-INDUCED LIVER INJURY 238 0.0076
287 BONE MARROW FAILURE 154 0.0076
288 RENAL CYST 60 0.0075
289 PERIPHERAL SENSORY NEUROPATHY 44 0.0075
290 CREATININE RENAL CLEARANCE DECREASED 30 0.0075
291 HEPATOCELLULAR INJURY 106 0.0075
292 BLOOD CREATINE INCREASED 33 0.0074
293 ARTHRALGIA 3041 0.0073
294 JAUNDICE 196 0.0073
295 PERICARDIAL EFFUSION 168 0.0073
296 APPETITE DISORDER 48 0.0072
297 MOUTH ULCERATION 152 0.0072
298 IMMUNE THROMBOCYTOPENIA 33 0.0072
299 BODY HEIGHT DECREASED 77 0.0072
300 CONGESTIVE CARDIOMYOPATHY 30 0.0072
301 HYPERTRIGLYCERIDAEMIA 42 0.0072
302 IRON DEFICIENCY 32 0.0071
303 FEBRILE BONE MARROW APLASIA 30 0.0071
304 BLOOD ALBUMIN DECREASED 56 0.0071
305 THYROID MASS 27 0.0070
306 EPISTAXIS 525 0.0070
307 FAECES SOFT 51 0.0070
308 HORMONE LEVEL ABNORMAL 34 0.0070
309 IMMUNE SYSTEM DISORDER 91 0.0069
310 HEPATIC FAILURE 207 0.0069
311 SUSPECTED OFF LABEL USE 31 0.0069
312 GOITRE 28 0.0068
313 VEIN DISORDER 34 0.0068
314 LABORATORY TEST ABNORMAL 200 0.0068
315 NODULE 88 0.0067
316 BRAIN FOG 105 0.0067
317 CYSTITIS 213 0.0067
318 HAEMATURIA 229 0.0067
319 FAECES HARD 26 0.0067
320 CHAPPED LIPS 29 0.0067
321 RENAL FUNCTION TEST ABNORMAL 31 0.0067
322 TOOTH EXTRACTION 83 0.0067
323 SPINAL COMPRESSION FRACTURE 55 0.0066
324 GENERAL PHYSICAL CONDITION ABNORMAL 45 0.0066
325 GENERAL PHYSICAL HEALTH DETERIORATION 767 0.0066
326 GINGIVAL SWELLING 29 0.0066
327 VITAMIN D DEFICIENCY 64 0.0066
328 HEPATIC PAIN 28 0.0066
329 ODYNOPHAGIA 39 0.0065
330 GINGIVAL PAIN 52 0.0065
331 OESOPHAGEAL CANDIDIASIS 26 0.0065
332 TENDONITIS 101 0.0065
333 ATELECTASIS 63 0.0065
334 DERMATITIS 135 0.0064
335 TRICUSPID VALVE INCOMPETENCE 51 0.0064
336 BLOOD THYROID STIMULATING HORMONE INCREASED 59 0.0064
337 HYPOKALAEMIA 295 0.0064
338 SENSITIVE SKIN 47 0.0064
339 PULMONARY TOXICITY 45 0.0064
340 AORTIC VALVE INCOMPETENCE 27 0.0063
341 ANAL FISSURE 34 0.0063
342 ASTHENIA 2382 0.0063
343 TINNITUS 291 0.0063
344 CARDIO-RESPIRATORY ARREST 263 0.0063
345 NECROSIS 35 0.0063
346 CONSTIPATION 1371 0.0063
347 HYPERBILIRUBINAEMIA 65 0.0063
348 POLYARTHRITIS 33 0.0063
349 HAIR GROWTH ABNORMAL 43 0.0062
350 VITAMIN D DECREASED 53 0.0062
351 HAEMORRHOIDAL HAEMORRHAGE 30 0.0061
352 DIARRHOEA 3961 0.0061
353 AGEUSIA 153 0.0061
354 BUNDLE BRANCH BLOCK LEFT 26 0.0061
355 SPINAL DISORDER 58 0.0061
356 MYALGIA 1039 0.0061
357 PULMONARY EMBOLISM 578 0.0061
358 PELVIC FRACTURE 47 0.0060
359 BLOOD UREA INCREASED 101 0.0060
360 STRESS CARDIOMYOPATHY 35 0.0060
361 DEPRESSED MOOD 318 0.0060
362 HEPATIC ENZYME ABNORMAL 30 0.0060
363 GINGIVAL BLEEDING 82 0.0060
364 FEELING OF DESPAIR 28 0.0060
365 ORAL DISCOMFORT 83 0.0060
366 COMPRESSION FRACTURE 32 0.0060
367 GRANULOCYTOPENIA 34 0.0060
368 UROSEPSIS 55 0.0060
369 OSTEOPOROSIS 245 0.0060
370 DERMATITIS BULLOUS 43 0.0059
371 TOOTH DISORDER 132 0.0059
372 PRODUCT DOSE OMISSION IN ERROR 168 0.0059
373 SKIN ATROPHY 34 0.0059
374 PANCYTOPENIA 330 0.0059
375 CORONAVIRUS INFECTION 39 0.0059
376 SKIN LESION 161 0.0059
377 SLEEP DISORDER 413 0.0058
378 NIGHT SWEATS 188 0.0058
379 PLATELET COUNT INCREASED 76 0.0058
380 EYE PAIN 328 0.0058
381 VARICOSE VEIN 30 0.0058
382 SPINAL OSTEOARTHRITIS 51 0.0058
383 HAEMORRHOIDS 113 0.0058
384 LUNG INFILTRATION 51 0.0058
385 DRUG INTOLERANCE 557 0.0058
386 YELLOW SKIN 27 0.0058
387 TENSION 35 0.0057
388 BLOOD PRESSURE SYSTOLIC INCREASED 112 0.0057
389 BREAST CANCER FEMALE 153 0.0057
390 COUGH 1604 0.0057
391 NAUSEA 4507 0.0057
392 SKIN MASS 38 0.0057
393 BACK PAIN 1316 0.0057
394 COMA 269 0.0056
395 OSTEOARTHRITIS 237 0.0056
396 MITRAL VALVE INCOMPETENCE 63 0.0056
397 C-REACTIVE PROTEIN INCREASED 202 0.0055
398 FRACTURE 105 0.0055
399 GASTROINTESTINAL PAIN 61 0.0055
400 LIVER INJURY 136 0.0055
401 MUSCLE ATROPHY 70 0.0055
402 METABOLIC DISORDER 32 0.0055
403 FEBRILE NEUTROPENIA 364 0.0055
404 HIATUS HERNIA 71 0.0055
405 CARDIOMYOPATHY 81 0.0055
406 GASTRITIS 144 0.0055
407 DYSPEPSIA 538 0.0055
408 TACHYCARDIA 484 0.0054
409 CHILLS 638 0.0054
410 CEREBRAL ISCHAEMIA 28 0.0054
411 URINARY TRACT INFECTION 927 0.0054
412 PYELONEPHRITIS 47 0.0054
413 DRY SKIN 723 0.0054
414 HYPOPHOSPHATAEMIA 40 0.0054
415 GINGIVITIS 29 0.0054
416 ELECTROCARDIOGRAM ABNORMAL 42 0.0053
417 ESCHERICHIA INFECTION 44 0.0053
418 DRY EYE 267 0.0053
419 AFFECTIVE DISORDER 42 0.0053
420 SCIATICA 85 0.0053
421 SPINAL FRACTURE 106 0.0053
422 HYPERCHOLESTEROLAEMIA 51 0.0053
423 GASTROINTESTINAL INFECTION 47 0.0052
424 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 34 0.0052
425 HYPERAESTHESIA 43 0.0052
426 GASTROINTESTINAL MOTILITY DISORDER 28 0.0052
427 HERPES VIRUS INFECTION 30 0.0052
428 HEPATITIS 133 0.0052
429 FEELING COLD 144 0.0052
430 TOOTH INFECTION 68 0.0052
431 BLOOD PRESSURE DIASTOLIC DECREASED 38 0.0051
432 HYPERGLYCAEMIA 187 0.0051
433 JAW DISORDER 28 0.0051
434 CELLULITIS 257 0.0051
435 BLOOD MAGNESIUM DECREASED 44 0.0051
436 LIVER DISORDER 225 0.0051
437 OESOPHAGITIS 55 0.0050
438 HYPOPHAGIA 128 0.0050
439 CEREBRAL DISORDER 37 0.0050
440 RENAL IMPAIRMENT 420 0.0050
441 OROPHARYNGEAL DISCOMFORT 45 0.0050
442 NEURALGIA 121 0.0050
443 HYPERTHYROIDISM 72 0.0050
444 ORAL HERPES 96 0.0049
445 FLANK PAIN 46 0.0049
446 PULMONARY FIBROSIS 94 0.0049
447 HYPOMAGNESAEMIA 68 0.0049
448 BLOOD SODIUM DECREASED 92 0.0049
449 ACUTE MYELOID LEUKAEMIA 76 0.0049
450 PIGMENTATION DISORDER 30 0.0049
451 TONGUE DISORDER 35 0.0048
452 DRUG RESISTANCE 123 0.0048
453 GAIT INABILITY 160 0.0048
454 CHROMATURIA 108 0.0048
455 ARTERIOSCLEROSIS 45 0.0048
456 THIRST 85 0.0048
457 SYNCOPE 476 0.0048
458 CATARACT 282 0.0047
459 ELECTROLYTE IMBALANCE 55 0.0047
460 ARTHROPOD BITE 35 0.0047
461 CONJUNCTIVITIS 87 0.0047
462 SEPSIS 522 0.0047
463 WEIGHT DECREASED 1305 0.0047
464 PRODUCTIVE COUGH 223 0.0047
465 VOMITING 2195 0.0047
466 HEPATIC ENZYME INCREASED 318 0.0047
467 SKIN FISSURES 91 0.0047
468 HEPATITIS CHOLESTATIC 28 0.0046
469 PYREXIA 1603 0.0046
470 NEUROTOXICITY 81 0.0046
471 LIMB DISCOMFORT 143 0.0046
472 RESPIRATORY RATE INCREASED 41 0.0046
473 HEPATITIS ACUTE 30 0.0046
474 DERMATITIS ACNEIFORM 28 0.0046
475 PHARYNGITIS 57 0.0046
476 CHOLECYSTITIS ACUTE 26 0.0046
477 NERVE INJURY 51 0.0046
478 ABDOMINAL PAIN 1061 0.0046
479 ABNORMAL LOSS OF WEIGHT 31 0.0045
480 SKIN INFECTION 51 0.0045
481 CHOLELITHIASIS 149 0.0045
482 OSTEONECROSIS 149 0.0045
483 DRY MOUTH 368 0.0045
484 DEEP VEIN THROMBOSIS 294 0.0045
485 DENTAL CARIES 50 0.0045
486 PAIN IN EXTREMITY 1330 0.0045
487 BLOOD DISORDER 36 0.0045
488 NEUTROPHIL COUNT INCREASED 46 0.0045
489 RHINORRHOEA 290 0.0045
490 SENSORY DISTURBANCE 72 0.0045
491 ORAL CANDIDIASIS 59 0.0045
492 IMPAIRED QUALITY OF LIFE 64 0.0044
493 VERTIGO 271 0.0044
494 CENTRAL NERVOUS SYSTEM LESION 61 0.0044
495 MASS 62 0.0044
496 FEELING OF BODY TEMPERATURE CHANGE 26 0.0044
497 PULMONARY OEDEMA 198 0.0044
498 INFLAMMATION 228 0.0044
499 LIP DRY 40 0.0044
500 OEDEMA PERIPHERAL 536 0.0044
501 RASH PUSTULAR 32 0.0044
502 UTERINE LEIOMYOMA 32 0.0044
503 POOR QUALITY SLEEP 94 0.0044
504 MOVEMENT DISORDER 140 0.0044
505 BLOOD POTASSIUM DECREASED 131 0.0044
506 ABDOMINAL PAIN UPPER 896 0.0043
507 PETECHIAE 45 0.0043
508 PULMONARY THROMBOSIS 47 0.0043
509 ILLNESS 442 0.0043
510 PNEUMOTHORAX 68 0.0043
511 SKIN DISORDER 143 0.0043
512 DIVERTICULITIS 118 0.0043
513 HEPATIC CIRRHOSIS 80 0.0043
514 SUDDEN DEATH 45 0.0042
515 GASTROENTERITIS 62 0.0042
516 COVID-19 744 0.0042
517 MENISCUS INJURY 26 0.0042
518 APHONIA 59 0.0042
519 CARDIAC FAILURE 338 0.0042
520 PAIN IN JAW 119 0.0042
521 LIVER FUNCTION TEST ABNORMAL 122 0.0042
522 RENAL TUBULAR NECROSIS 41 0.0042
523 INSOMNIA 1112 0.0042
524 TOOTH FRACTURE 46 0.0042
525 DYSPNOEA 2355 0.0042
526 IMMUNODEFICIENCY 62 0.0042
527 BRONCHIECTASIS 28 0.0042
528 HOSPICE CARE 41 0.0041
529 OROPHARYNGEAL PAIN 384 0.0041
530 TENDERNESS 43 0.0041
531 ANAL INCONTINENCE 37 0.0041
532 ATRIAL FIBRILLATION 400 0.0041
533 DYSGEUSIA 305 0.0041
534 RHINITIS 33 0.0041
535 HUNGER 57 0.0041
536 CANDIDA INFECTION 69 0.0041
537 DIVERTICULUM 29 0.0041
538 ERYTHEMA MULTIFORME 38 0.0041
539 TOXIC SKIN ERUPTION 41 0.0041
540 PERIPHERAL SWELLING 627 0.0041
541 UPPER RESPIRATORY TRACT INFECTION 188 0.0041
542 MUSCULOSKELETAL PAIN 213 0.0041
543 HYPOKINESIA 59 0.0041
544 THROMBOSIS 326 0.0040
545 SKIN REACTION 57 0.0040
546 AUTOIMMUNE HEPATITIS 28 0.0040
547 ACUTE KIDNEY INJURY 616 0.0040
548 SINUS DISORDER 79 0.0040
549 SKIN EXFOLIATION 336 0.0040
550 DYSPHAGIA 378 0.0040
551 PELVIC PAIN 72 0.0040
552 SCAB 45 0.0039
553 DYSPHONIA 230 0.0039
554 NASAL DISCOMFORT 31 0.0039
555 MALAISE 1709 0.0039
556 MEMORY IMPAIRMENT 535 0.0039
557 ABDOMINAL DISCOMFORT 653 0.0039
558 ARRHYTHMIA 184 0.0039
559 RASH PRURITIC 210 0.0039
560 OSTEOMYELITIS 70 0.0039
561 VISUAL IMPAIRMENT 478 0.0039
562 SENSORY LOSS 31 0.0038
563 GLOSSODYNIA 86 0.0038
564 DYSSTASIA 112 0.0038
565 TENDON PAIN 29 0.0038
566 NASOPHARYNGITIS 706 0.0038
567 IMPAIRED HEALING 125 0.0038
568 COLITIS 144 0.0038
569 VISION BLURRED 521 0.0038
570 LIPASE INCREASED 29 0.0038
571 PRODUCT PRESCRIBING ERROR 90 0.0038
572 THERAPY CHANGE 37 0.0038
573 HAEMOLYSIS 29 0.0038
574 PARAESTHESIA 590 0.0037
575 BLOOD PRESSURE INCREASED 572 0.0037
576 TOOTH ABSCESS 38 0.0037
577 BREAST TENDERNESS 28 0.0037
578 LUNG DISORDER 182 0.0037
579 PAROSMIA 28 0.0037
580 MUSCLE STRAIN 32 0.0037
581 RETINAL DETACHMENT 34 0.0037
582 PRURITUS 1421 0.0037
583 FEMUR FRACTURE 114 0.0037
584 DISCOMFORT 224 0.0037
585 DYSURIA 135 0.0037
586 SINUS TACHYCARDIA 52 0.0037
587 ABDOMINAL DISTENSION 381 0.0036
588 WOUND 102 0.0036
589 PAIN 2238 0.0036
590 ABDOMINAL PAIN LOWER 92 0.0036
591 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 30 0.0036
592 VIRAL INFECTION 121 0.0036
593 NEOPLASM MALIGNANT 242 0.0036
594 RETCHING 77 0.0036
595 DISEASE RECURRENCE 171 0.0036
596 CARDIOMEGALY 44 0.0036
597 SKIN HAEMORRHAGE 53 0.0036
598 DEHYDRATION 475 0.0036
599 DECUBITUS ULCER 29 0.0036
600 DIZZINESS 1775 0.0036
601 COVID-19 PNEUMONIA 42 0.0036
602 BRONCHITIS 263 0.0035
603 URINE OUTPUT DECREASED 31 0.0035
604 NOCTURIA 43 0.0035
605 ULCER 56 0.0035
606 HYPOAESTHESIA 525 0.0035
607 MENTAL IMPAIRMENT 85 0.0035
608 RESPIRATORY TRACT INFECTION 91 0.0035
609 CHOKING 68 0.0035
610 SKIN DISCOLOURATION 160 0.0035
611 HYPOTHYROIDISM 111 0.0035
612 NECK PAIN 194 0.0035
613 FRUSTRATION TOLERANCE DECREASED 28 0.0035
614 INTERVERTEBRAL DISC DEGENERATION 32 0.0035
615 HEPATIC FUNCTION ABNORMAL 129 0.0035
616 BLOOD IRON DECREASED 41 0.0035
617 SUPRAVENTRICULAR TACHYCARDIA 33 0.0034
618 RED BLOOD CELL SEDIMENTATION RATE INCREASED 38 0.0034
619 MUSCULOSKELETAL STIFFNESS 300 0.0034
620 DIARRHOEA HAEMORRHAGIC 32 0.0034
621 RIB FRACTURE 70 0.0034
622 INCREASED APPETITE 65 0.0034
623 MALNUTRITION 38 0.0034
624 TEMPERATURE INTOLERANCE 35 0.0034
625 GAIT DISTURBANCE 648 0.0034
626 NEPHROPATHY TOXIC 38 0.0034
627 ACUTE CORONARY SYNDROME 28 0.0034
628 HYPERTENSION 714 0.0034
629 IRON DEFICIENCY ANAEMIA 31 0.0034
630 OEDEMA 182 0.0034
631 WEIGHT FLUCTUATION 35 0.0033
632 DRY THROAT 34 0.0033
633 HYPOALBUMINAEMIA 26 0.0033
634 PULMONARY CONGESTION 44 0.0033
635 INFLUENZA 371 0.0033
636 BLOOD POTASSIUM INCREASED 54 0.0033
637 LOCALISED INFECTION 80 0.0033
638 HYPONATRAEMIA 186 0.0033
639 HYPOACUSIS 142 0.0033
640 HERPES ZOSTER 189 0.0033
641 FALL 1090 0.0033
642 BLOOD PRESSURE ABNORMAL 65 0.0033
643 SARS-COV-2 TEST POSITIVE 43 0.0033
644 EMBOLISM 27 0.0032
645 BODY TEMPERATURE DECREASED 32 0.0032
646 SEASONAL ALLERGY 46 0.0032
647 MOOD ALTERED 88 0.0032
648 POOR QUALITY PRODUCT ADMINISTERED 34 0.0032
649 DEPRESSION 728 0.0032
650 CHOLECYSTITIS 38 0.0032
651 ARTHRITIS 249 0.0032
652 EYE DISORDER 104 0.0032
653 ERUCTATION 61 0.0031
654 DECREASED ACTIVITY 34 0.0031
655 MUSCLE SPASMS 578 0.0031
656 EMOTIONAL DISORDER 97 0.0031
657 FAECES DISCOLOURED 68 0.0031
658 RESTLESS LEGS SYNDROME 57 0.0031
659 DIABETES MELLITUS 238 0.0031
660 BLOOD TRIGLYCERIDES INCREASED 55 0.0031
661 HIP FRACTURE 100 0.0031
662 ANKLE FRACTURE 48 0.0031
663 SOMNOLENCE 624 0.0031
664 DIZZINESS POSTURAL 30 0.0031
665 APATHY 45 0.0031
666 TENDON RUPTURE 38 0.0031
667 HEADACHE 1929 0.0031
668 TUMOUR LYSIS SYNDROME 27 0.0031
669 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 52 0.0031
670 UPPER LIMB FRACTURE 61 0.0031
671 CYST 38 0.0031
672 THERAPY CESSATION 157 0.0031
673 ILEUS 38 0.0031
674 PURPURA 27 0.0030
675 RENAL DISORDER 142 0.0030
676 EPILEPSY 93 0.0030
677 MOTOR DYSFUNCTION 31 0.0030
678 BURNING SENSATION 213 0.0030
679 SCAR 52 0.0030
680 SECRETION DISCHARGE 38 0.0030
681 CRYING 110 0.0030
682 NASAL CONGESTION 177 0.0030
683 SMALL INTESTINAL OBSTRUCTION 37 0.0030
684 GASTROINTESTINAL DISORDER 269 0.0030
685 COGNITIVE DISORDER 140 0.0030
686 FLATULENCE 170 0.0030
687 RASH 1298 0.0030
688 LOWER RESPIRATORY TRACT INFECTION 135 0.0030
689 PHOTOSENSITIVITY REACTION 49 0.0030
690 NERVOUSNESS 155 0.0030
691 PNEUMONIA 958 0.0030
692 GASTROOESOPHAGEAL REFLUX DISEASE 237 0.0029
693 SKIN ULCER 76 0.0029
694 PAIN OF SKIN 79 0.0029
695 MULTIPLE ORGAN DYSFUNCTION SYNDROME 83 0.0029
696 BLOOD CHOLESTEROL INCREASED 136 0.0029
697 APHASIA 88 0.0029
698 EOSINOPHILIA 51 0.0029
699 RECTAL HAEMORRHAGE 125 0.0029
700 MYELODYSPLASTIC SYNDROME 42 0.0029
701 WEIGHT INCREASED 649 0.0029
702 HAEMATOMA 75 0.0029
703 MICTURITION URGENCY 33 0.0029
704 FEELING ABNORMAL 692 0.0029
705 HEART RATE IRREGULAR 65 0.0029
706 INFECTION 415 0.0029
707 BALANCE DISORDER 246 0.0028
708 ARTHROPATHY 158 0.0028
709 WHITE BLOOD CELL COUNT INCREASED 109 0.0028
710 CONTUSION 273 0.0028
711 DELUSION 44 0.0028
712 RENAL PAIN 30 0.0028
713 DRUG ERUPTION 50 0.0028
714 SPEECH DISORDER 147 0.0028
715 KIDNEY INFECTION 55 0.0028
716 PARALYSIS 40 0.0028
717 SINUS BRADYCARDIA 27 0.0028
718 PALLOR 76 0.0028
719 ANXIETY 794 0.0028
720 ABSCESS 44 0.0028
721 DRUG INTERACTION 437 0.0028
722 DEAFNESS 72 0.0028
723 FLUID RETENTION 140 0.0027
724 TOOTH LOSS 57 0.0027
725 INTERVERTEBRAL DISC PROTRUSION 60 0.0027
726 LETHARGY 157 0.0027
727 AMNESIA 176 0.0027
728 MOBILITY DECREASED 194 0.0027
729 CHEST PAIN 500 0.0027
730 OBESITY 43 0.0027
731 MOOD SWINGS 86 0.0027
732 BRAIN INJURY 27 0.0027
733 MUSCULAR WEAKNESS 306 0.0027
734 PNEUMOCYSTIS JIROVECII PNEUMONIA 27 0.0027
735 QUALITY OF LIFE DECREASED 36 0.0027
736 HYPERLIPIDAEMIA 32 0.0027
737 EAR PAIN 52 0.0027
738 RESPIRATORY DISORDER 80 0.0027
739 INTENTIONAL DOSE OMISSION 76 0.0027
740 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 128 0.0027
741 CHEST DISCOMFORT 272 0.0027
742 BLOOD GLUCOSE ABNORMAL 49 0.0027
743 WOUND INFECTION 29 0.0026
744 LIGAMENT SPRAIN 26 0.0026
745 ANOSMIA 38 0.0026
746 EYE HAEMORRHAGE 35 0.0026
747 PALPITATIONS 307 0.0026
748 POLLAKIURIA 109 0.0026
749 URINARY RETENTION 87 0.0026
750 RASH MACULO-PAPULAR 58 0.0026
751 PRODUCT USE IN UNAPPROVED INDICATION 645 0.0026
752 BODY TEMPERATURE INCREASED 53 0.0026
753 MENTAL DISORDER 113 0.0026
754 GLAUCOMA 50 0.0026
755 SNEEZING 58 0.0026
756 THROAT IRRITATION 116 0.0026
757 HYPERSOMNIA 74 0.0026
758 HAEMOPTYSIS 72 0.0026
759 COORDINATION ABNORMAL 36 0.0026
760 ACUTE HEPATIC FAILURE 35 0.0026
761 LOWER LIMB FRACTURE 49 0.0025
762 PRODUCT AVAILABILITY ISSUE 58 0.0025
763 HEART RATE INCREASED 251 0.0025
764 AGRANULOCYTOSIS 47 0.0025
765 BLISTER 142 0.0025
766 INTESTINAL OBSTRUCTION 95 0.0025
767 RESTLESSNESS 92 0.0025
768 VAGINAL HAEMORRHAGE 109 0.0025
769 RASH ERYTHEMATOUS 120 0.0025
770 LIMB INJURY 68 0.0025
771 TACHYPNOEA 34 0.0025
772 INTERNATIONAL NORMALISED RATIO INCREASED 71 0.0025
773 SKIN LACERATION 27 0.0025
774 HYPERHIDROSIS 319 0.0025
775 EYE SWELLING 92 0.0025
776 SINUSITIS 253 0.0025
777 DERMATITIS ALLERGIC 31 0.0025
778 THERAPEUTIC RESPONSE DECREASED 149 0.0025
779 CLOSTRIDIUM DIFFICILE COLITIS 26 0.0024
780 PRODUCT DISPENSING ERROR 53 0.0024
781 UVEITIS 33 0.0024
782 RENAL FAILURE 323 0.0024
783 RASH MACULAR 85 0.0024
784 WRIST FRACTURE 29 0.0024
785 PRODUCT USE COMPLAINT 38 0.0024
786 MUSCLE TIGHTNESS 39 0.0024
787 DEVICE RELATED INFECTION 37 0.0024
788 EYE INFECTION 27 0.0024
789 PRODUCT USE ISSUE 447 0.0024
790 FACE OEDEMA 40 0.0024
791 MIDDLE INSOMNIA 44 0.0024
792 GOUT 42 0.0023
793 JOINT INJURY 50 0.0023
794 DEMENTIA 65 0.0023
795 ACUTE RESPIRATORY DISTRESS SYNDROME 41 0.0023
796 MUSCULOSKELETAL DISORDER 44 0.0023
797 HEMIPARESIS 39 0.0023
798 INFLUENZA LIKE ILLNESS 189 0.0023
799 OFF LABEL USE 2008 0.0023
800 ACUTE RESPIRATORY FAILURE 44 0.0023
801 SWELLING 213 0.0023
802 MELAENA 50 0.0023
803 ANGINA PECTORIS 65 0.0023
804 FOOT FRACTURE 43 0.0023
805 DISTURBANCE IN ATTENTION 122 0.0023
806 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 118 0.0023
807 UPPER GASTROINTESTINAL HAEMORRHAGE 38 0.0023
808 IRRITABILITY 135 0.0022
809 DEATH 1900 0.0022
810 ERYTHEMA 453 0.0022
811 DISSEMINATED INTRAVASCULAR COAGULATION 31 0.0022
812 SWELLING FACE 142 0.0022
813 BRONCHOSPASM 31 0.0022
814 GASTROENTERITIS VIRAL 39 0.0022
815 COLD SWEAT 38 0.0022
816 BACK DISORDER 35 0.0022
817 THINKING ABNORMAL 40 0.0021
818 OXYGEN SATURATION DECREASED 120 0.0021
819 TRANSIENT ISCHAEMIC ATTACK 72 0.0021
820 LIP SWELLING 71 0.0021
821 JOINT SWELLING 257 0.0021
822 BASAL CELL CARCINOMA 33 0.0021
823 CONDITION AGGRAVATED 643 0.0021
824 EYE PRURITUS 71 0.0021
825 PULMONARY HYPERTENSION 44 0.0021
826 HYPERSENSITIVITY 392 0.0021
827 URINARY INCONTINENCE 62 0.0021
828 CONFUSIONAL STATE 337 0.0021
829 CLOSTRIDIUM DIFFICILE INFECTION 45 0.0021
830 BRAIN OEDEMA 26 0.0021
831 THERAPEUTIC RESPONSE UNEXPECTED 92 0.0020
832 PERITONITIS 42 0.0020
833 GLYCOSYLATED HAEMOGLOBIN INCREASED 51 0.0020
834 CEREBRAL INFARCTION 49 0.0020
835 BLOOD PRESSURE FLUCTUATION 48 0.0020
836 NEPHROLITHIASIS 91 0.0020
837 TUBULOINTERSTITIAL NEPHRITIS 37 0.0020
838 MIGRAINE 188 0.0020
839 BLOOD URINE PRESENT 37 0.0019
840 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 138 0.0019
841 HYPERKALAEMIA 68 0.0019
842 HYPOXIA 68 0.0019
843 RASH PAPULAR 43 0.0019
844 PROCEDURAL PAIN 53 0.0019
845 TREMOR 317 0.0019
846 FEELING HOT 117 0.0019
847 FEAR 51 0.0019
848 GASTRIC DISORDER 65 0.0019
849 ILL-DEFINED DISORDER 115 0.0019
850 THERAPY INTERRUPTED 135 0.0019
851 THYROID DISORDER 29 0.0019
852 PANCREATITIS ACUTE 42 0.0019
853 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 32 0.0019
854 BONE LOSS 28 0.0019
855 HERNIA 36 0.0019
856 PRODUCT SUBSTITUTION ISSUE 107 0.0019
857 HYPOAESTHESIA ORAL 28 0.0019
858 WHEEZING 110 0.0019
859 FIBROMYALGIA 45 0.0018
860 ACUTE MYOCARDIAL INFARCTION 54 0.0018
861 LACTIC ACIDOSIS 59 0.0018
862 BLOOD PRESSURE DECREASED 121 0.0018
863 PRODUCT DOSE OMISSION ISSUE 535 0.0018
864 LYMPHOMA 28 0.0018
865 EAR INFECTION 48 0.0018
866 CEREBRAL HAEMORRHAGE 64 0.0018
867 CEREBROVASCULAR ACCIDENT 301 0.0018
868 RHABDOMYOLYSIS 74 0.0018
869 HEAD INJURY 56 0.0018
870 HAEMATOCHEZIA 97 0.0018
871 COLON CANCER 26 0.0017
872 COAGULOPATHY 29 0.0017
873 GASTRIC ULCER 33 0.0017
874 MUSCLE TWITCHING 40 0.0017
875 TREATMENT FAILURE 143 0.0017
876 HAEMORRHAGE 180 0.0017
877 BLOOD GLUCOSE INCREASED 323 0.0017
878 LEUKOCYTOSIS 31 0.0017
879 FREQUENT BOWEL MOVEMENTS 46 0.0017
880 MANIA 28 0.0017
881 PRODUCT PRESCRIBING ISSUE 37 0.0017
882 DISORIENTATION 67 0.0017
883 THERAPY NON-RESPONDER 75 0.0017
884 AMENORRHOEA 29 0.0017
885 FUNGAL INFECTION 55 0.0016
886 HYPOGLYCAEMIA 80 0.0016
887 TOXICITY TO VARIOUS AGENTS 276 0.0016
888 OCULAR HYPERAEMIA 77 0.0016
889 RESPIRATORY FAILURE 118 0.0016
890 HYPOTENSION 324 0.0016
891 CARDIOVASCULAR DISORDER 41 0.0016
892 SWOLLEN TONGUE 50 0.0016
893 PRODUCT DOSE OMISSION 104 0.0016
894 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 285 0.0016
895 CHRONIC KIDNEY DISEASE 120 0.0016
896 PRURITUS GENERALISED 34 0.0016
897 CARDIAC DISORDER 146 0.0016
898 BACTERIAL INFECTION 29 0.0016
899 STAPHYLOCOCCAL INFECTION 51 0.0015
900 BRADYCARDIA 82 0.0015
901 HEPATIC CANCER 37 0.0015
902 IRRITABLE BOWEL SYNDROME 33 0.0015
903 URTICARIA 255 0.0015
904 TYPE 2 DIABETES MELLITUS 51 0.0015
905 ASTHMA 171 0.0015
906 GALLBLADDER DISORDER 27 0.0015
907 ECZEMA 79 0.0015
908 SKIN IRRITATION 69 0.0015
909 EYE IRRITATION 85 0.0015
910 PROTEINURIA 28 0.0015
911 LOSS OF CONSCIOUSNESS 187 0.0015
912 ANGER 49 0.0014
913 PANCREATITIS 76 0.0014
914 RASH GENERALISED 37 0.0014
915 HALLUCINATION, VISUAL 30 0.0014
916 DYSARTHRIA 53 0.0014
917 POST PROCEDURAL COMPLICATION 27 0.0014
918 IMPAIRED WORK ABILITY 30 0.0014
919 CARDIAC FAILURE CONGESTIVE 112 0.0014
920 SEIZURE 161 0.0014
921 PREMATURE BABY 41 0.0014
922 STEVENS-JOHNSON SYNDROME 30 0.0013
923 PRODUCT ADMINISTRATION ERROR 27 0.0013
924 SEPTIC SHOCK 58 0.0013
925 ABORTION SPONTANEOUS 53 0.0013
926 COLITIS ULCERATIVE 59 0.0013
927 RESPIRATORY DISTRESS 36 0.0013
928 THROAT TIGHTNESS 35 0.0013
929 FOETAL EXPOSURE DURING PREGNANCY 105 0.0013
930 DIABETIC KETOACIDOSIS 31 0.0013
931 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 70 0.0013
932 DELIRIUM 43 0.0012
933 SUICIDAL IDEATION 113 0.0012
934 CORONARY ARTERY DISEASE 37 0.0012
935 AGITATION 88 0.0012
936 LUNG NEOPLASM MALIGNANT 49 0.0012
937 EXPOSURE DURING PREGNANCY 74 0.0012
938 INTENTIONAL PRODUCT MISUSE 104 0.0012
939 NIGHTMARE 41 0.0012
940 PANIC ATTACK 43 0.0012
941 SURGERY 69 0.0012
942 ANGIOEDEMA 52 0.0012
943 TREATMENT NONCOMPLIANCE 64 0.0012
944 CONTRAINDICATED PRODUCT ADMINISTERED 35 0.0012
945 NERVOUS SYSTEM DISORDER 36 0.0012
946 BONE DENSITY DECREASED 36 0.0011
947 ROAD TRAFFIC ACCIDENT 48 0.0011
948 HEART RATE DECREASED 39 0.0011
949 ACNE 84 0.0011
950 DRUG INEFFECTIVE 1460 0.0011
951 CARDIAC ARREST 91 0.0011
952 METABOLIC ACIDOSIS 35 0.0011
953 ABASIA 27 0.0011
954 VISUAL ACUITY REDUCED 36 0.0011
955 MATERNAL EXPOSURE DURING PREGNANCY 96 0.0011
956 FLUSHING 109 0.0011
957 ACCIDENTAL OVERDOSE 39 0.0011
958 BLOOD CREATINE PHOSPHOKINASE INCREASED 30 0.0010
959 ADVERSE DRUG REACTION 93 0.0010
960 INTENTIONAL PRODUCT USE ISSUE 90 0.0010
961 SKIN BURNING SENSATION 73 0.0010
962 EMOTIONAL DISTRESS 123 0.0010
963 ABNORMAL BEHAVIOUR 39 0.0010
964 PLASMA CELL MYELOMA 38 0.0010
965 MYOCARDIAL INFARCTION 161 0.0009
966 BLOOD GLUCOSE DECREASED 44 0.0009
967 HALLUCINATION 69 0.0009
968 GASTROINTESTINAL HAEMORRHAGE 72 0.0009
969 INJURY 60 0.0009
970 ANAPHYLACTIC REACTION 45 0.0008
971 DRUG DOSE OMISSION 134 0.0008
972 MEDICATION ERROR 43 0.0008
973 DYSKINESIA 31 0.0008
974 INFUSION RELATED REACTION 48 0.0007
975 DRUG EFFECT INCOMPLETE 26 0.0007
976 DEPRESSED LEVEL OF CONSCIOUSNESS 28 0.0007
977 ADVERSE EVENT 65 0.0007
978 UNDERDOSE 49 0.0007
979 UNEVALUABLE EVENT 50 0.0007
980 HOSPITALISATION 100 0.0007
981 EXTRA DOSE ADMINISTERED 26 0.0006
982 RHEUMATOID ARTHRITIS 72 0.0006
983 PRODUCT STORAGE ERROR 51 0.0006
984 INCORRECT DOSE ADMINISTERED 122 0.0005
985 PSORIASIS 54 0.0004
986 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 29 0.0004
987 OVERDOSE 75 0.0003
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 67 0.0003
989 INJECTION SITE PAIN 101 0.0003
990 PRODUCT QUALITY ISSUE 44 0.0003
991 NO ADVERSE EVENT 49 0.0003